World's Best Scientists 2026 revealed!
Francesca Ceccherini-Silberstein

Francesca Ceccherini-Silberstein

D-Index & Metrics

Microbiology

D-Index
42
Citations
7246
World Ranking
5343
National Ranking
178

Francesca Ceccherini-Silberstein publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Francesca Ceccherini-Silberstein sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 320 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Francesca Ceccherini-Silberstein D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Francesca Ceccherini-Silberstein sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 42 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Francesca Ceccherini-Silberstein is affiliated with the University of Rome Tor Vergata in Italy. Their research spans several interconnected fields within medicine, primarily focusing on infectious diseases, epidemiology, virology, hepatology, and molecular biology.

The scientist has contributed extensively to the body of knowledge on viral infections, with significant work addressing HIV/AIDS drug development and treatment, hepatitis B and C virus studies, and SARS-CoV-2 and COVID-19 research. Other important research areas include liver disease diagnosis and treatment and HIV/AIDS research and interventions.

Frequent co-authors collaborating in their research efforts include:

  • Carlo Federico Perno
  • Maria Mercedes Santoro
  • Valentina Svicher
  • Loredana Sarmati
  • Lorenzo Piermatteo

The researcher has published regularly in a variety of scientific journals. Among the most common publication venues are:

  • Journal of Hepatology
  • Viruses
  • Digestive and Liver Disease
  • Journal of Antimicrobial Chemotherapy
  • Research Square

Recent papers by Francesca Ceccherini-Silberstein cover current and relevant topics in virology and infectious diseases, including:

  • Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses (2020, Drug Resistance Updates)
  • Whole exome HBV DNA integration is independent of the intrahepatic HBV reservoir in HBeAg-negative chronic hepatitis B (2020, Gut)
  • Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile (2022, Microbiology Spectrum)
  • Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy (2020, Journal of Hepatology)
  • Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 (2021, Virology Journal)

Their research integrates molecular biology techniques and epidemiological data to address challenges in viral infection management and treatment strategies. This multidisciplinary approach supports advancements in the understanding of virus-host interactions and therapeutic interventions. The scientific output reflects sustained activity in areas critical to global health.

Best Publications

  • 2019 update of the drug resistance mutations in HIV-1.

    Annemarie M. Wensing;Vincent Calvez;Francesca Ceccherini-Silberstein;Charlotte Charpentier

  • Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients

    Miriam Lichtner;Paola Cicconi;Serena Vita;Alessandro Cozzi-Lepri

  • Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018.

    Maria C. Sorbo;Valeria Cento;Velia C. Di Maio;Anita Y.M. Howe

  • European recommendations for the clinical use of HIV drug resistance testing: 2011 update

    Anne-Mieke Vandamme;Ricardo J Camacho;Francesca Ceccherini-Silberstein;Andreu de Luca;Andreu de Luca

  • Characterization and structural analysis of HIV-1 integrase conservation

    Francesca Ceccherini-Silberstein;Isabelle Malet;Roberta D'Arrigo;Andrea Antinori

  • Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

    Alessandro Cozzi-Lepri;Marc Noguera-Julian;Francesca Di Giallonardo;Rob Schuurman

  • The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress-Driven Mucus Depletion and Exacerbates Intestinal Inflammation.

    Federica Laudisi;Davide Di Fusco;Vincenzo Dinallo;Carmine Stolfi

  • HCV Genotypes Are Differently Prone to the Development of Resistance to Linear and Macrocyclic Protease Inhibitors

    Valeria Cento;Carmen Mirabelli;Romina Salpini;Salvatore Dimonte

  • Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection.

    Valentina Svicher;Valeria Cento;Martina Bernassola;Maria Neumann-Fraune

  • Involvement of Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutations in the Regulation of Resistance to Nucleoside Inhibitors

    Valentina Svicher;Tobias Sing;Maria Mercedes Santoro;Federica Forbici

  • Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies

    Velia C Di Maio;Valeria Cento;Ilaria Lenci;Marianna Aragri

  • Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades

    Tomas Doyle;David T. Dunn;Francesca Ceccherini-Silberstein;Carmen De Mendoza

  • Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.

    Anna Artese;Valentina Svicher;Giosuè Costa;Romina Salpini

  • Emerging patterns and implications of HIV-1 integrase inhibitor resistance.

    Anna Maria Geretti;Daniele Armenia;Francesca Ceccherini-Silberstein

  • Reliability and Clinical Relevance of the HIV-1 Drug Resistance Test in Patients With Low Viremia Levels

    Maria Mercedes Santoro;Lavinia Fabeni;Daniele Armenia;Claudia Alteri

  • Identification of the minimal conserved structure of HIV-1 protease in the presence and absence of drug pressure.

    Francesca Ceccherini-Silberstein;Fulvio Erba;Federico Gago;Ada Bertoli

  • Understanding HIV Compartments and Reservoirs

    Valentina Svicher;Francesca Ceccherini-Silberstein;Andrea Antinori;Stefano Aquaro

  • Novel Human Immunodeficiency Virus Type 1 Protease Mutations Potentially Involved in Resistance to Protease Inhibitors

    Valentina Svicher;Francesca Ceccherini-Silberstein;Fulvio Erba;Maria Santoro

  • New raltegravir resistance pathways induce broad cross-resistance to all currently used integrase inhibitors

    Isabelle Malet;Isabelle Malet;Laura Gimferrer Arriaga;Laura Gimferrer Arriaga;Anna Artese;Giosuè Costa

  • Characterization and Structural Analysis of Novel Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Involved in the Regulation of Resistance to Nonnucleoside Inhibitors

    Francesca Ceccherini-Silberstein;Valentina Svicher;Tobias Sing;Anna Artese

  • Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

    Annalisa Mondi;Alessandro Cozzi-Lepri;Alessandro Tavelli;Stefano Rusconi

  • Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1

    Manuela Cota;Andrea Kleinschmidt;Francesca Ceccherini-Silberstein;Francesca Aloisi

Frequent Co-Authors

Carlo Federico Perno
Carlo Federico Perno University of Milan
Massimo Andreoni
Massimo Andreoni University of Rome Tor Vergata
Andrea Antinori
Andrea Antinori Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani
Antonella d'Arminio Monforte
Antonella d'Arminio Monforte University of Milan
Cristina Mussini
Cristina Mussini University of Modena and Reggio Emilia
Claudio Maria Mastroianni
Claudio Maria Mastroianni Sapienza University of Rome
Alessandro Cozzi-Lepri
Alessandro Cozzi-Lepri University College London
Stefano Alcaro
Stefano Alcaro Magna Graecia University
Antonio Craxì
Antonio Craxì University of Palermo
Anne-Geneviève Marcelin
Anne-Geneviève Marcelin Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology opens diverse career opportunities, many of which intersect with healthcare and data management fields. For those interested in the administrative side of health services, pursuing a master in health information management salary offers insight into a lucrative career path managing and protecting patient data.

Choosing the right educational program is crucial. Many students opt for an accredited online health information management degree cahiim, which ensures high standards and better job prospects in the competitive healthcare industry.

For quicker entry into the healthcare administration workforce, exploring a fast track medical billing and coding certificate online can be a practical choice. This certification allows graduates to start working swiftly in a critical support role.

Additionally, a variety of online healthcare degrees are available for microbiology graduates looking to expand their qualifications into related healthcare fields, offering flexible learning options suited to different career goals.

Best Scientists Citing Francesca Ceccherini-Silberstein

Trending Scientists

Recently Published Articles